Concepedia

Publication | Closed Access

Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial.

DOI

156

Citations

18

References

1998

Year

Cesare Guglielmi, F. Gómez, Thierry Philip, Anton Hagenbeek, Maurizio Martelli, Catherine Sebban, Nöel Milpied, Dominique Bron, Jean‐Yves Cahn, R. Somers,
Journal of Clinical Oncology

Abstract

Time to relapse may be used to stratify patients at time of first relapse of intermediate to high-grade non-Hodgkin's lymphoma.

References

YearCitations

Page 1